Dahms Bradford D. - Insider Non-Derivative Transactions at Theseus Pharmaceuticals, Inc. (THRX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 14, 2024, Dahms Bradford D.'s relationship to Theseus Pharmaceuticals, Inc. (THRX) is Officer (President and CFO), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other THRX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Dahms Bradford D. - Insider Non-Derivative Transactions of THRX Common Stock

Dahms Bradford D. - Insider Non-Derivative Transactions at THRX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 15, 2024	U -- (Common Stock)	8150.23	0	0